Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Sahin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ibrahim Halil Sahin is an oncologist specializing in gastrointestinal cancer based in Pittsburgh, PA. He completed a fellowship in Hematology and Medical Oncology at Emory University School of Medicine in 2020 and an internal medicine residency at Icahn School of Medicine at Mount Sinai. He obtained his medical degree from Hacettepe University FOM in 2009. Dr. Sahin serves as an Assistant Professor at both UPMC Hillman Cancer Center and H. Lee Moffitt Cancer Center and Research Institute. He has published several research articles on various cancer-related topics, including colorectal cancer and precision medicine. In 2020, he was recognized with an ASCO Merit Award.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2020
Hacettepe University FOMClass of 2009
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine
Certifications & Licensure
MI State Medical License 2025 - 2028
PA State Medical License 2022 - 2026
FL State Medical License 2020 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO Merit Award ASCO, 2020
Publications & Presentations
PubMed
- A Systematic Review of the Efficacy of KRAS p.G12C Inhibitors in Metastatic Colorectal Cancer: The Current State of Science.Jeffrey Mathew Boby, Nosakhare Ilerhunmwuwa, Jame Mathew Benny, Paola Zinser Peniche, Doga Kahramangil Baytar
Cancer Investigation. 2026-05-01 - DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Re...Rohit Das, Jeffrey Kleinberger, Tarek Sawas, Abigail I Wald, Robert Bubar
Gastroenterology. 2026-03-27 - Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer.Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, Moh'd Khushman, Axel Grothey
NPJ Precision Oncology. 2026-02-26
Authored Content
- The ASCO Gastrointestinal Cancers Symposium 2020 at a GlanceFebruary 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
